Summary by Moomoo AI
Heart Test Laboratories, a Texas-based company, has filed a Form 8-K with the SEC, reporting significant corporate actions as of May 6, 2024. The company, which trades under the symbol HSCS on the Nasdaq Stock Market, has been notified by Nasdaq of non-compliance with the Minimum Bid Price Requirement since August 2, 2023. Despite being granted an extension until July 29, 2024, to meet this requirement, Heart Test Laboratories received a staff determination on May 9, 2024, to delist its securities due to the common stock's closing bid price falling to $0.10 or less for ten consecutive trading days. The company plans to appeal this determination and has until May 16, 2024, to file a hearing request, which will stay the delisting pending the Panel's decision. In...Show More